Investigation of effect of Oral Nanomicelle Curcumin in Patients with Non-atopic Bronchial Asthma

Phase 3

• Conditions: Asthma.; Chronic lower respiratory diseases; J40-J47

• Registration Number: IRCT20161226031584N2
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 August 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

non atoic asthma
informed consent

Exclusion Criteria

smoker
COPD
pregnancy/lactation
heart ,liver,kidney disorder and gallbladder disease
acute exacerbation within one month ago

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
FEV1,ACT ,AQLQ. Timepoint: Measuring the FEV1-ACT, AQLQ questionnaire every two weeks to two months. Method of measurement: questionnaire ,spirometry,physical exam.